NEWGEN BIOPHARMA CORP. (OTCMKTS:NEWG) Files An 8-K Other Events

0

NEWGEN BIOPHARMA CORP. (OTCMKTS:NEWG) Files An 8-K Other Events

Item 8.01 Other Events.

Name Change

On March 31, 2017, NewGen BioPharma Corp., a Nevada corporation
(the Company), filed an application to change its name to
Greenwind Holdings Inc. The name change is being made to Nevada
Revised Statutes 92A.180 and 92A.200 by merging a wholly-owned
subsidiary of the Company with and into the Company. The Company
is the surviving corporation in the merger, and in connection
with the merger, the Companys Articles of Incorporation will be
amended to change the Companys corporate name to Greenwind
Holdings Inc. On April 3, 2017, the Company filed an Issuer
Company Related Action Notification with FINRA to effect the name
change, and the Companys application is currently under review by
FINRA. The name change will be effective on or about April 17,
2017 upon review and approval by FINRA.


About NEWGEN BIOPHARMA CORP. (OTCMKTS:NEWG)

NewGen BioPharma Corp., formerly Greenwind NRG Inc., is a development-stage company. The Company intends to operate in the business of off the grid wind power systems for residential, cabin, recreational vehicle (RV), boat and shop use. The Company will provide an opportunity for customers to research and purchase off-the-grid wind turbines capable of producing energy for use in residential homes and elsewhere. Its focus market will be Ireland. It intends to purchase turbines and sell them to retail consumers throughout Ireland and to expand throughout North America. The Company seeks to focus on users seeking an alternative, renewable source of energy for a range of uses. Its products will have a rated wind speed of approximately 20 miles per hour. Its over two larger turbines will have the ability to generate approximately five kilowatts per hour. The Company intends to generate revenues by selling and offering installation and maintenance services of off-the-grid wind turbines.

NEWGEN BIOPHARMA CORP. (OTCMKTS:NEWG) Recent Trading Information

NEWGEN BIOPHARMA CORP. (OTCMKTS:NEWG) closed its last trading session 00.00 at 1.56 with 500 shares trading hands.